September 16, 2024

Supplemental Table S4 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening

Key Points

Key points are not available for this paper at this time.

Abstract

Supplemental Table S4 shows the top five most influential inputs based on the one-way sensitivity analyses on each of the mean change in costs, QALYs, and life-years with the addition of DS reflex to common co-testing screening strategies

KI fragen

Bookmark

Cite This Study

Harper et al. (Mon,) studied this question.

synapsesocial.com/papers/68e586b5b6db64358752330b https://doi.org/https://doi.org/10.1158/1940-6207.27026954.v1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplemental Table S4 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
2Data from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
3Supplemental Figure S2 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
4Supplemental Figure S2 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024
5Supplemental Table S1 from Cost-Effectiveness of p16/Ki-67 Dual-Stained Cytology Reflex Following Co-Testing with hrHPV Genotyping for Cervical Cancer Screening2024

KI fragen

Bookmark